In humans a 12 month OS change from 35-40% to 65% is impressive. I would be super excited about a therapy for my pup that would add 6 months to my pup's life. The median survival improvement from 307 days to 478 days is enough for me to ask for that therapy instead of chemo and amputation for my pup's osteosarcoma or other HER2 driven cancers.
I think the treatment was in top of chemo and amputation. Anyhow, I agree with you.
A few thoughts: Yes, this is literally animal testing.
This study was published 2.5 years ago.
Overall survival at 1 year at 65 % vs 35-40 with standard of care.
No serious side effects.
The peptide sequence was carefully selected.
Original scientific article link for those interested. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379704/
In humans a 12 month OS change from 35-40% to 65% is impressive. I would be super excited about a therapy for my pup that would add 6 months to my pup's life. The median survival improvement from 307 days to 478 days is enough for me to ask for that therapy instead of chemo and amputation for my pup's osteosarcoma or other HER2 driven cancers.
I think the treatment was in top of chemo and amputation. Anyhow, I agree with you.